138 related articles for article (PubMed ID: 38336628)
1. Bioactive adrenomedullin and interleukin-6 in COVID-19: potential biomarkers of acute kidney injury and critical illness.
Leininger SB; Staudner ST; Vogel MJ; Mustroph J; Hubauer U; Wallner S; Lehn P; Burkhardt R; Meindl C; Hanses F; Zimmermann M; Maier LS; Hupf J; Jungbauer CG
BMC Nephrol; 2024 Feb; 25(1):52. PubMed ID: 38336628
[TBL] [Abstract][Full Text] [Related]
2. The value of bioactive adrenomedullin and dipeptidyl peptidase 3 to predict short-term unfavourable outcomes after cardiac surgery: A prospective cohort study.
van Lier D; Beunders R; Kox M; Pickkers P
Eur J Anaesthesiol; 2022 Apr; 39(4):342-351. PubMed ID: 35102040
[TBL] [Abstract][Full Text] [Related]
3. Circulating bioactive adrenomedullin as a marker of sepsis, septic shock and critical illness.
Lundberg OHM; Lengquist M; Spångfors M; Annborn M; Bergmann D; Schulte J; Levin H; Melander O; Frigyesi A; Friberg H
Crit Care; 2020 Nov; 24(1):636. PubMed ID: 33148300
[TBL] [Abstract][Full Text] [Related]
4. Bioactive adrenomedullin in sepsis patients in the emergency department is associated with mortality, organ failure and admission to intensive care.
Lundberg OHM; Rosenqvist M; Bronton K; Schulte J; Friberg H; Melander O
PLoS One; 2022; 17(4):e0267497. PubMed ID: 35482727
[TBL] [Abstract][Full Text] [Related]
5. Bioactive adrenomedullin a prognostic biomarker in patients with mild to moderate dyspnea at the emergency department: an observational study.
Bronton K; Wessman T; Gränsbo K; Schulte J; Hartmann O; Melander O
Intern Emerg Med; 2022 Mar; 17(2):541-550. PubMed ID: 34173962
[TBL] [Abstract][Full Text] [Related]
6. Utility of Measuring Circulating Bio-Adrenomedullin and Proenkephalin for 30-Day Mortality Risk Prediction in Patients with COVID-19 and Non-COVID-19 Interstitial Pneumonia in the Emergency Department.
Papasidero ID; Valli G; Marin D; Del Sasso A; De Magistris A; Cennamo E; Casalboni S; De Marco F; Rocchi R; Ndogmo Beumo B; Cusani V; Gaudio M; Hartmann O; Bergman A; Ruggieri MP; Di Somma S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557054
[No Abstract] [Full Text] [Related]
7. Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study.
van Lier D; Deniau B; Santos K; Hartmann O; Dudoignon E; Depret F; Plaud B; Laterre PF; Mebazaa A; Pickkers P
ERJ Open Res; 2023 Jan; 9(1):. PubMed ID: 36628268
[TBL] [Abstract][Full Text] [Related]
8. Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis: the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shock-1 (AdrenOSS-1) study.
Mebazaa A; Geven C; Hollinger A; Wittebole X; Chousterman BG; Blet A; Gayat E; Hartmann O; Scigalla P; Struck J; Bergmann A; Antonelli M; Beishuizen A; Constantin JM; Damoisel C; Deye N; Di Somma S; Dugernier T; François B; Gaudry S; Huberlant V; Lascarrou JB; Marx G; Mercier E; Oueslati H; Pickkers P; Sonneville R; Legrand M; Laterre PF;
Crit Care; 2018 Dec; 22(1):354. PubMed ID: 30583748
[TBL] [Abstract][Full Text] [Related]
9. Postoperatively increased bioactive adrenomedullin is related to adverse outcome after complex aortic surgery.
Gombert A; Doukas P; Marx G; Hartmann O; Bergmann D; Schulte J; Stoppe C; Jacobs M; Simon T
Vasa; 2020 Apr; 49(3):187-194. PubMed ID: 32011218
[No Abstract] [Full Text] [Related]
10. Dipeptidyl-peptidase 3 and IL-6: potential biomarkers for diagnostics in COVID-19 and association with pulmonary infiltrates.
Staudner ST; Leininger SB; Vogel MJ; Mustroph J; Hubauer U; Meindl C; Wallner S; Lehn P; Burkhardt R; Hanses F; Zimmermann M; Scharf G; Hamer OW; Maier LS; Hupf J; Jungbauer CG
Clin Exp Med; 2023 Dec; 23(8):4919-4935. PubMed ID: 37733154
[TBL] [Abstract][Full Text] [Related]
11. 30 Days Mortality Prognostic Value of POCT Bio-Adrenomedullin and Proenkephalin in Patients with Sepsis in the Emergency Department.
Casalboni S; Valli G; Terlizzi F; Mastracchi M; Fidelio G; De Marco F; Bernardi C; Chieruzzi A; Curcio A; De Cicco F; Colella N; Papasidero ID; Tartarone E; Ruggieri MP; Di Somma S
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36556987
[No Abstract] [Full Text] [Related]
12. Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.
McMahon BA; Galligan M; Redahan L; Martin T; Meaney E; Cotter EJ; Murphy N; Hannon C; Doran P; Marsh B; Nichol A; Murray PT
Am J Nephrol; 2019; 50(1):19-28. PubMed ID: 31203271
[TBL] [Abstract][Full Text] [Related]
13. Early prediction of COVID-19-associated acute kidney injury: Are serum NGAL and serum Cystatin C levels better than serum creatinine?
Pode Shakked N; de Oliveira MHS; Cheruiyot I; Benoit JL; Plebani M; Lippi G; Benoit SW; Henry BM
Clin Biochem; 2022 Apr; 102():1-8. PubMed ID: 35093314
[TBL] [Abstract][Full Text] [Related]
14. Plasma bioactive adrenomedullin on intensive care unit admission is associated with acute respiratory distress syndrome: an observational study.
Johnsson P; Fredriksson A; Tung C; Friberg H; Frigyesi A
Intensive Care Med Exp; 2023 Mar; 11(1):10. PubMed ID: 36864354
[TBL] [Abstract][Full Text] [Related]
15. Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure.
Self WH; Storrow AB; Hartmann O; Barrett TW; Fermann GJ; Maisel AS; Struck J; Bergmann A; Collins SP
Am J Emerg Med; 2016 Feb; 34(2):257-62. PubMed ID: 26577429
[TBL] [Abstract][Full Text] [Related]
16. Plasma bioactive adrenomedullin predicts outcome after acute stroke in early rehabilitation.
Shafieesabet A; Jauert N; Hartmann O; Arlt B; Joebges M; Doehner W
Sci Rep; 2023 Mar; 13(1):4873. PubMed ID: 36964268
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of Bioactive Adrenomedullin in Critically Ill Patients with COVID-19 in Germany: An Observational Cohort Study.
Simon TP; Stoppe C; Breuer T; Stiehler L; Dreher M; Kersten A; Kluge S; Karakas M; Zechendorf E; Marx G; Martin L
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33924637
[TBL] [Abstract][Full Text] [Related]
18. Proenkephalin A and bioactive adrenomedullin are useful for risk prognostication in cardiac surgery.
Hill A; Bergmann D; Schulte J; Zayat R; Marx G; Simon TP; Mossanen J; Brücken A; Stoppe C
Front Cardiovasc Med; 2022; 9():1017867. PubMed ID: 36756642
[TBL] [Abstract][Full Text] [Related]
19. [The study on pro-adrenomedullin as a new biomarker in sepsis prognosis and risk stratification].
Kang FX; Wang RL; Yu KL; Wei Q
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Aug; 20(8):452-5. PubMed ID: 18687169
[TBL] [Abstract][Full Text] [Related]
20. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.
Legramante JM; Mastropasqua M; Susi B; Porzio O; Mazza M; Miranda Agrippino G; D Agostini C; Brandi A; Giovagnoli G; Di Lecce VN; Bernardini S; Minieri M
PLoS One; 2017; 12(11):e0187702. PubMed ID: 29161297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
